A patient-controlled registry allows imaging data to be shared without placing undue burdens on the patients, providers or infrastructures.
Use of a patient-controlled access registry allows imaging data to be shared between unaffiliated health care facilities without placing undue burdens on the patients, providers or infrastructures, said researchers in an article published by the Journal of the American Informatics Association.
Researchers from Wake Forest School of Medicine in Winston-Salem, N.C., built a patient-controlled access-key registry (PCARE), which allowed participating patients to electronically verify their identities. The goal was to avoid having patients hand-deliver images or CDs, or burdensome requests to be sent between institutions.
Through the PCARE portal, access keys were issued by the image source facilities and when the keys were digitally signed by the patients for requesting facilities, the images became available for retrieval. In addition to ease of information transfer, this type of system would help protect patient privacy, the authors said.
“The same framework can also be used to realize a longitudinal virtual electronic health record,” the authors wrote.
A prototype has been implemented to demonstrate the feasibility of such a framework, as well as the benefits of the approach.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.